This is the leading study to analyze the influence of serum cystatin C level—showing sensitivity and specificity—on the disease-free survival and overall survival probability of DLBCL patients; DLBCL denotes the most common subtype of NHL, it is accounting for 30%–40% amongst lymphoma cases [1,2]. The gene discussed is CST3; the disease is non-Hodgkin lymphoma.